Drug Profile
Colchicine - Hikma Pharmaceuticals
Alternative Names: MitigareLatest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator Hikma Pharmaceuticals
- Class Anti-ischaemics; Antigouts; Antineoplastics; Colchicum alkaloids; Small molecules; Vascular disorder therapies
- Mechanism of Action Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Gout